Tugba Tunali-Akbay

Prof. Tugba Tunali-Akbay


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2010 in Journal of Pharmacy & Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
TTTugba Tunali-Akbay
Tugba Tunali-Akbay
OSOzer Sehirli
Ozer Sehirli
FEFeriha Ercan
Feriha Ercan
GSGoksel Sener
Goksel Sener
Purpose. The aim of this study to investigate the possible protective effect of resveratrol on some liver and serum/plasma parameters in methotrexate induced toxicity in rats. Methotrexate is used widely to treat various neoplastic diseases such as acute lymphoblastic leukemia, lymphoma, solid cancers, and autoimmune diseases. We hypothesized that resveratrol has a potential to decrease the oxidant damage in MTX-induced hepatic injury. Methods. Following a single dose of methotrexate (20 mg/kg, i.p.), either saline or resveratrol (10 mg/kg, orally) was administered for 5 days. After decapitation of the rats, trunk blood was obtained and the liver was removed to measure malondialdehyde and glutathione levels, myeloperoxidase and thromboplastic activities and collagen content. Aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase activity were measured in the serum samples, while TNF-α and total antioxidant capacity were assayed in plasma samples. Results. Our results showed that MTX administration increased the hepatic malondialdehyde levels, myeloperoxidase and thromboplastic activities and collagen contents and decreased glutathione, while these alterations were reversed in resveratrol-treated group. Elevated aspartate aminotransferase and alanine aminotransferase activities and TNF-α level observed following MTX treatment was depressed with resveratrol. Conclusions. The present study showed that resveratrol protects against methotrexate-induced hepatic injury and may be of therapeutic potential in alleviating the systemic side effects of chemotherapeutics.

24 July 2010 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
FIF. Isik
F. Isik
TTTugba Tunali-Akbay
Tugba Tunali-Akbay
AYA. Yarat
A. Yarat
ZGZ. Genc
Z. Genc
RPR. Pisiriciler
R. Pisiriciler
GSGöksel Sener
Göksel Sener


1 January 2005 in Life Sciences
Verified
Journal Article
Closed access
TTTugba Tunali-Akbay
Tugba Tunali-Akbay
GSGoksel Sener
Goksel Sener
AYAysen Yarat
Aysen Yarat
NENesrin Emekli
Nesrin Emekli

1 December 2019 in Burns
Verified
Journal Article
Closed access
OOOzan Ozcan
Ozan Ozcan
HIHazal Ipekci
Hazal Ipekci
BABurcin Alev
Burcin Alev
UUUnsal Veli Ustundag
Unsal Veli Ustundag
EAEsin Ak
Esin Ak
TTTugba Tunali-Akbay
Tugba Tunali-Akbay

27 October 2006 in Phytotherapy Research
Verified
Journal Article
Open access
PDF file
TTTugba Tunali-Akbay
Tugba Tunali-Akbay
GSGoksel Sener
Goksel Sener
HSHanife Salvarli
Hanife Salvarli
OSOzer Sehirli
Ozer Sehirli
AYAysen Yarat
Aysen Yarat
This study was designed to determine the possible protective effect of Ginkgo biloba extract (EGb) against Hg II‐induced oxidative damage and also thromboplastic activity in the aorta and heart tissues. Wistar albino rats of either sex (200–250 g) were divided into four groups. Rats were injected intraperitoneally with (1) control (C) group: 0.9% NaCl; (2) EGb group: Ginkgo biloba extract (Abdi Ibrahim Pharmaceutical Company, Istanbul, Turkey) at a dose of 50 mg/kg/day; (3) Hg group: a single dose of 5 mg/kg mercuric chloride (HgCl2); and (4) Hg + EGb group: First day EGb at a dose of 50 mg/kg/day, i.p., 1 hour after HgCl2 (5 mg/kg) injection; following four days EGb at a dose 50 mg/kg/day, i.p. After decapitation of the rats, trunk blood was obtained and serum tumor necrosis factor‐α (TNF‐α), lactate dehydrogenase (LDH) activity, and malondialdehyde (MDA) and glutathione (GSH) levels were analysed. In the aorta and heart tissues total protein, MDA, GSH levels and thromboplastic activity were determined. The results revealed that HgCl2 induced oxidative tissue damage, as evidenced by increases in MDA levels and decreased GSH levels both in serum and tissue samples. Thromboplastic activity was increased significantly following Hg administration, which verifies the cardiotoxic effects of HgCl2. Serum LDH and TNF‐α were elevated in the Hg group compared with the control group. Since EGb treatment reversed these responses, it seems likely that Ginkgo biloba extract can protect the cardiovascular tissues against HgCl2‐induced oxidative damage. Copyright © 2006 John Wiley & Sons, Ltd.